Strategic advice & regulatory analysis

Our experienced consultants can provide insight on all regulatory requirements for France and address any questions related to:

  • Drug Registration
  • Early Access Programmes
  • Post MAA activities
  • Promotional material review
  • Quality System & Audits
  • Interactions with Healthcare professionals: Compliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
  • Pharmacovigilance
  • Pricing & reimbursement
PICTOS-BLUE-REG_400x400_6

Discover our last white Paper

Learn more